{"certainAgreement":{"piSponsorEmployee":false,"restrictiveAgreement":false},"limitationsAndCaveats":{"description":"3/34 pts signed consent but never received therapy due to progressive malignancy that precluded their ability to receive the experimental therapy. These participants were not assigned to a cohort."},"pointOfContact":{"email":"steven_pavletic@nih.gov","organization":"National Cancer Institute","phone":"301-402-4899","title":"Dr. Steven Pavletic"}}